Patent ID: 7317029

Claim:
A method of treating cancer, wherein the cancer is selected from the group consisting of breast carcinoma, ovarian carcinoma, and lung carcinoma in a human suffering therefrom, comprising administering to a human in need of such treatment an effective amount of a compound having the Formula IV: or a pharmaceutically acceptable salt or prodrug or tautomers thereof, wherein: R 1 -R 3 are independently hydrogen, halo, haloalkyl, aryl, fused aryl, carbocyclic, a heterocyclic group, a heteroaryl group, alkyl, alkenyl, alkynyl, arylalkyl, arylalkenyl, arylalkynyl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkynyl, carbocycloalkyl, heterocycloalkyl, hydroxyalkyl, nitro, amino, cyano, acylamino, hydroxy, thiol, acyloxy, azido, alkoxy, aryloxy, heteroaryloxy, arylalkoxy, heteroarylalkoxy, haloalkoxy, carboxy, carbonylamido or alkylthiol, each of which is optionally substituted; Q is S, O or NR 9 , wherein R 9 is hydrogen, optionally substituted alkyl, optionally substituted cycloalkyl or optionally substituted aryl; and Ring A is an optionally substituted heterocycle or carbocycle.